Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

In the United States of America, as per the Centers for Disease Control and Prevention (CDC), breast cancer is the most ...

Kate Rouch, OpenAI's Chief Marketing Officer, recently revealed her invasive breast cancer diagnosis and credited the company ...

The drug becomes active when exposed to a specific type of light, usually from a laser or LED (light-emitting diodes), and ...

In 2020, brain tumor was ranked as the 10th most common kind of tumor among Indians. While there is no specified known cause, ...

Adding an ICI to neoadjuvant chemotherapy can improve pCR rates and may improve OS in patients with MIBC, research suggests.

The future of non-invasive cancer therapy is bright. Liver tumors can now be destroyed—without radiation, chemotherapy or surgery—thanks to new medical technology known as histotripsy.

Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) ...

M42 will integrate SOPHiA GENETICS’ MSK-ACCESS® powered with SOPHiA DDM™ technology into its testing infrastructure ...